CRISTY SHARP: Open Payments
NPI 1467475038 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 71 payments from 12 companies in 2025. Trend: 2023 $2,833 · 2024 $1,462 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $263 |
| Novo Nordisk Inc | 11 | $157 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Amgen Inc. | 18 | $145 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Almatica Pharma LLC | 1 | $30 |
| PFIZER INC. | 1 | $20 |
| Cleerly, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
Products named: QULIPTA, OTEZLA, BREZTRI, Rybelsus, UBRELVY, Ozempic, FARXIGA, REPATHA.
Industry payments across TX — which companies pay providers there.
